Solid lipid nanoparticles for targeted brain drug delivery

被引:414
作者
Blasi, Paolo [1 ]
Glovagnoli, Stefano [1 ]
Schoubben, Aurelie [1 ]
Ricci, Maurizio [1 ]
Rossi, Carlo [1 ]
机构
[1] Univ Perugia, Sch Pharm, Dept Chem & Technol Drugs, I-06123 Perugia, Italy
关键词
CNS drug delivery; brain targeting; blood-brain barrier (BBB); solid lipid nanoparticles (SLN); NLC; LDC; polymeric nanoparticles; polysorbate 80 (Tween((R)) 80);
D O I
10.1016/j.addr.2007.04.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present review discusses the potential use of solid lipid nanoparticles for brain drug targeting purposes. The state of the art on surfactant-coated poly(alkylcyanoacrylate) nanoparticles specifically designed for brain targeting is given by emphasizing the transfer of this technology to solid lipid matrices. The available literature on solid lipid nanoparticles and related carriers for brain drug targeting is revised as well. The potential advantages of the use of solid lipid nanoparticles over polymeric nanoparticles are accounted on the bases of a lower cytotoxicity, higher drug loading capacity, and best production scalability. Solid lipid nanoparticles physicochemical characteristics are also particularly regarded in order to address the critical issues related to the development of suitable brain targeting formulations. A critical consideration on the potential application of such technology as related to the current status of brain drug development is also given. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:454 / 477
页数:24
相关论文
共 253 条
[61]   Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase [J].
Freitas, C ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :125-132
[62]   Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system [J].
Friese, A ;
Seiller, E ;
Quack, G ;
Lorenz, B ;
Kreuter, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) :103-109
[63]   Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin:: Pharmacokinetics and tissue distribution after i.v. administration to rats [J].
Fundarò, A ;
Cavalli, R ;
Bargoni, A ;
Vighetto, D ;
Zara, GP ;
Gasco, MR .
PHARMACOLOGICAL RESEARCH, 2000, 42 (04) :337-343
[64]   Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor [J].
Furumoto, K ;
Nagayama, S ;
Ogawara, K ;
Takakura, Y ;
Hashida, M ;
Higaki, K ;
Kimura, T .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (01) :133-141
[65]   Polyethylene glycol coated (pegylated) liposomal doxorubicin - Rationale for use in solid tumours [J].
Gabizon, A ;
Martin, F .
DRUGS, 1997, 54 (Suppl 4) :15-21
[66]  
Gaillard Pieter J, 2005, Expert Opin Drug Deliv, V2, P299, DOI 10.1517/17425247.2.2.299
[67]   Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].
Gao, KP ;
Jiang, XG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 310 (1-2) :213-219
[68]   Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration [J].
Gao, XL ;
Tao, WX ;
Lu, W ;
Zhang, QZ ;
Zhang, Y ;
Jiang, XG ;
Fu, SK .
BIOMATERIALS, 2006, 27 (18) :3482-3490
[69]   New strategies for repairing the injured spinal cord: the role of stem cells [J].
Garbossa, D. ;
Fontanella, M. ;
Fronda, C. ;
Benevello, C. ;
Muraca, G. ;
Ducati, A. ;
Vercelli, A. .
NEUROLOGICAL RESEARCH, 2006, 28 (05) :500-504
[70]   Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? [J].
Garcia-Garcia, E ;
Andrieux, K ;
Gil, S ;
Couvreur, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 298 (02) :274-292